Rhenman & Partners Asset Management AB as of Sept. 30, 2016
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 107 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Shire | 4.2 | $27M | 410k | 64.89 | |
Eli Lilly & Co. (LLY) | 3.2 | $21M | 255k | 80.26 | |
Alexion Pharmaceuticals | 3.1 | $20M | 162k | 122.54 | |
Celgene Corporation | 3.1 | $19M | 186k | 104.53 | |
Pfizer | 3.0 | $19M | 555k | 33.87 | |
Allergan | 2.9 | $18M | 80k | 230.31 | |
UnitedHealth (UNH) | 2.9 | $18M | 130k | 140.00 | |
Biogen Idec (BIIB) | 2.8 | $18M | 57k | 313.03 | |
Incyte Corporation (INCY) | 2.8 | $17M | 185k | 94.29 | |
Gilead Sciences | 2.6 | $16M | 207k | 79.12 | |
Medtronic | 2.3 | $15M | 169k | 86.40 | |
CVS Caremark Corporation (CVS) | 2.3 | $14M | 160k | 88.99 | |
BioMarin Pharmaceutical (BMRN) | 2.1 | $13M | 140k | 92.52 | |
Bristol Myers Squibb (BMY) | 2.0 | $13M | 237k | 53.92 | |
Merck & Co (MRK) | 2.0 | $13M | 200k | 62.41 | |
Teva Pharmaceutical Industries (TEVA) | 2.0 | $12M | 270k | 46.01 | |
Regeneron Pharmaceuticals (REGN) | 1.9 | $12M | 30k | 402.02 | |
Zimmer Holdings (ZBH) | 1.8 | $11M | 85k | 130.02 | |
CIGNA Corporation | 1.7 | $11M | 84k | 130.32 | |
Abiomed | 1.7 | $11M | 85k | 128.58 | |
Ariad Pharmaceuticals | 1.5 | $9.2M | 675k | 13.69 | |
Amgen (AMGN) | 1.5 | $9.2M | 55k | 166.81 | |
Alnylam Pharmaceuticals (ALNY) | 1.4 | $8.8M | 130k | 67.78 | |
Anthem | 1.3 | $8.5M | 67k | 125.31 | |
Hca Holdings (HCA) | 1.3 | $8.3M | 110k | 75.63 | |
Alkermes (ALKS) | 1.3 | $8.3M | 176k | 47.03 | |
Express Scripts Holding | 1.2 | $7.8M | 111k | 70.53 | |
Exelixis (EXEL) | 1.2 | $7.7M | 600k | 12.79 | |
Jazz Pharmaceuticals (JAZZ) | 1.2 | $7.3M | 60k | 121.48 | |
Endo International | 1.1 | $7.3M | 360k | 20.15 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $7.0M | 80k | 87.21 | |
Hologic (HOLX) | 1.1 | $7.0M | 180k | 38.83 | |
Abbvie (ABBV) | 1.1 | $6.9M | 110k | 63.07 | |
Nektar Therapeutics (NKTR) | 1.1 | $6.7M | 390k | 17.18 | |
Supernus Pharmaceuticals (SUPN) | 1.1 | $6.7M | 270k | 24.73 | |
Edwards Lifesciences (EW) | 1.1 | $6.6M | 55k | 120.56 | |
Horizon Pharma | 1.1 | $6.6M | 365k | 18.13 | |
Zeltiq Aesthetics | 1.0 | $6.3M | 160k | 39.22 | |
Dex (DXCM) | 0.9 | $5.7M | 65k | 87.66 | |
Endologix | 0.9 | $5.6M | 435k | 12.80 | |
Xencor (XNCR) | 0.9 | $5.5M | 225k | 24.49 | |
Centene Corporation (CNC) | 0.8 | $5.4M | 80k | 66.96 | |
Lion Biotechnologies | 0.8 | $5.3M | 650k | 8.23 | |
Walgreen Boots Alliance (WBA) | 0.8 | $5.2M | 65k | 80.62 | |
Rigel Pharmaceuticals | 0.8 | $5.1M | 1.4M | 3.67 | |
Nevro (NVRO) | 0.8 | $5.1M | 49k | 104.39 | |
Kite Pharma | 0.8 | $5.0M | 90k | 55.86 | |
Aetna | 0.8 | $4.8M | 42k | 115.45 | |
Omnicell (OMCL) | 0.7 | $4.5M | 119k | 38.30 | |
Humana (HUM) | 0.7 | $4.4M | 25k | 176.89 | |
Cardinal Health (CAH) | 0.7 | $4.3M | 55k | 77.70 | |
AmerisourceBergen (COR) | 0.7 | $4.3M | 53k | 80.78 | |
Macrogenics (MGNX) | 0.7 | $4.2M | 140k | 29.91 | |
Laboratory Corp. of America Holdings | 0.7 | $4.1M | 30k | 137.48 | |
McKesson Corporation (MCK) | 0.7 | $4.2M | 25k | 166.75 | |
Radius Health | 0.6 | $4.1M | 75k | 54.09 | |
Thermo Fisher Scientific (TMO) | 0.6 | $4.0M | 25k | 159.06 | |
Cempra | 0.6 | $3.9M | 161k | 24.20 | |
Universal Health Services (UHS) | 0.6 | $3.7M | 30k | 123.22 | |
Array BioPharma | 0.6 | $3.7M | 550k | 6.75 | |
DaVita (DVA) | 0.6 | $3.6M | 55k | 66.07 | |
NxStage Medical | 0.6 | $3.6M | 145k | 24.99 | |
Cooper Companies | 0.6 | $3.6M | 20k | 179.26 | |
Coherus Biosciences (CHRS) | 0.6 | $3.5M | 131k | 26.78 | |
Revance Therapeutics (RVNC) | 0.5 | $3.4M | 210k | 16.21 | |
Perrigo Company (PRGO) | 0.5 | $3.2M | 35k | 92.33 | |
Dynavax Technologies (DVAX) | 0.5 | $3.1M | 300k | 10.49 | |
Halozyme Therapeutics (HALO) | 0.5 | $3.0M | 250k | 12.08 | |
Chimerix (CMRX) | 0.5 | $3.0M | 550k | 5.54 | |
Portola Pharmaceuticals | 0.4 | $2.7M | 121k | 22.71 | |
Keryx Biopharmaceuticals | 0.4 | $2.7M | 500k | 5.31 | |
Neuroderm Ltd F | 0.4 | $2.7M | 145k | 18.49 | |
Rite Aid Corporation | 0.4 | $2.3M | 300k | 7.69 | |
Insulet Corporation (PODD) | 0.4 | $2.3M | 57k | 40.94 | |
Achillion Pharmaceuticals | 0.3 | $2.2M | 266k | 8.10 | |
Tesaro | 0.3 | $2.2M | 22k | 100.24 | |
Adamas Pharmaceuticals | 0.3 | $2.1M | 130k | 16.41 | |
Fibrogen (FGEN) | 0.3 | $2.2M | 104k | 20.70 | |
Intra Cellular Therapies (ITCI) | 0.3 | $2.1M | 135k | 15.24 | |
Neurocrine Biosciences (NBIX) | 0.3 | $2.0M | 40k | 50.64 | |
Esperion Therapeutics (ESPR) | 0.3 | $1.8M | 130k | 13.85 | |
Johnson & Johnson (JNJ) | 0.3 | $1.8M | 15k | 118.13 | |
Tandem Diabetes Care | 0.3 | $1.8M | 234k | 7.66 | |
Intercept Pharmaceuticals In | 0.3 | $1.6M | 10k | 164.59 | |
ACADIA Pharmaceuticals (ACAD) | 0.2 | $1.6M | 50k | 31.81 | |
Valeant Pharmaceuticals Int | 0.2 | $1.2M | 50k | 24.55 | |
Tetraphase Pharmaceuticals | 0.2 | $1.1M | 300k | 3.83 | |
Regulus Therapeutics | 0.2 | $990k | 300k | 3.30 | |
Anthera Pharmaceutcls | 0.1 | $945k | 300k | 3.15 | |
Catabasis Pharmaceuticals | 0.1 | $616k | 100k | 6.16 | |
Adverum Biotechnologies | 0.1 | $633k | 154k | 4.11 | |
Mednax (MD) | 0.1 | $596k | 9.0k | 66.25 | |
Orexigen Therapeutics | 0.1 | $398k | 120k | 3.32 | |
Mirati Therapeutics | 0.1 | $331k | 50k | 6.61 | |
Concert Pharmaceuticals I equity | 0.1 | $304k | 30k | 10.11 | |
Ocular Therapeutix (OCUL) | 0.0 | $275k | 40k | 6.87 | |
Microsoft Corporation (MSFT) | 0.0 | $181k | 3.1k | 57.60 | |
JPMorgan Chase & Co. (JPM) | 0.0 | $179k | 2.7k | 66.59 | |
Caterpillar (CAT) | 0.0 | $193k | 2.2k | 88.77 | |
Exxon Mobil Corporation (XOM) | 0.0 | $184k | 2.1k | 87.28 | |
Wells Fargo & Company (WFC) | 0.0 | $200k | 4.5k | 44.28 | |
Halliburton Company (HAL) | 0.0 | $190k | 4.2k | 44.88 | |
International Business Machines (IBM) | 0.0 | $182k | 1.1k | 158.85 | |
Qualcomm (QCOM) | 0.0 | $197k | 2.9k | 68.50 | |
Ford Motor Company (F) | 0.0 | $176k | 15k | 12.07 | |
Glaukos (GKOS) | 0.0 | $193k | 5.1k | 37.74 | |
Threshold Pharmaceuticals | 0.0 | $137k | 202k | 0.68 |